Kelsey Stephen Michael sold RVMD

September 11, 2025 · Form 4 insider transaction

Kelsey Stephen Michael sold 55,941 shares of Revolution Medicines, Inc. at $44.48 per share, a transaction worth $2.49M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
55,941
Price
$44.48
Total value
$2.49M
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 11, 2025
Filing dateSeptember 15, 2025
Shares owned after289,414
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025.; The transaction was executed in multiple trades in prices ranging from $44.12 to $44.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.; Includes 94,426 restricted stock units.

View the original Form 4 on SEC EDGAR